| |
RETINA |
| |
|
|
FRIDAY, FEBRUARY 22, 2019
|
HALL A |
| |
|
|
08:30-10:00
|
OPENING SESSION | Big Controversies in Ophthalmology in 2019
|
|
Chairs:
|
Neil Bressler, USA |
|
08:30-09:00
|
Debate I: Proliferative diabetic retinopathy: Five-year outcomes confirm anti-VEGF without PRP is an acceptable initial treatment
|
|
08:30-08:40
|
Yes: Susan Bressler, USA
|
| 08:40-08:50 |
No |
| 08:50-09:00 |
Discussion |
| |
|
09:00-09:30
|
Debate II: Neuro-protection in glaucoma: A viable pursuit
|
|
09:00-09:10
|
Yes: Christopher Leung, Hong Kong
|
| 09:10-09:20 |
No |
| 09:20-09:30 |
Discussion |
| |
|
09:30-10:00
|
Debate III: Atrophine should be used in children to prevent myopia
|
|
09:30-09:40
|
Yes: Tien Yin Wong, Singapore
|
|
09:40-09:50
|
No, not in all cases
|
|
09:50-10:00
|
Discussion |
| |
| 10:00-10:30 |
Visit to Exhibits - Coffee and Refreshment Break |
| |
|
10:30-12:00
|
RETINA I | Choroidal Neovascular Age-related Macular Degeneration
|
|
Chairs:
|
Xiaoxin Li, China; Adrian Koh, Singapore |
|
10:30-11:00
|
Debate I: Treat and extend regimens are superior to PRN regimens
|
|
10:30-10:40
|
Yes: Gemmy Cheung, Singapore
|
| 10:40-10:50 |
No: Susan Bressler, USA |
| 10:50-11:00 |
Discussion |
| |
|
11:00-11:30
|
Debate II: Large submacular hemorrhages typically should be managed initially with surgery, not anti-VEGF injections
|
|
11:00-11:10
|
Yes: Yaiji Sakamoto, Japan
|
| 11:10-11:20 |
No: Paisan Ruamviboonsuk, Thailand |
| 11:20-11:30 |
Discussion |
| |
|
11:30-12:00
|
Debate III: New agents or delivery devices represents a clinically relevant advance in managing neovascular AMD
|
| |
|
|
11:30-11:40
|
Yes: Jun Kong, China
|
|
11:40-11:50
|
No: Sherman Valero, Philippines
|
|
11:50-12:00
|
Discussion |
| |
| 12:00-12:15 |
Visit to Exhibits & Technical Break |
| |
| 12:15-13:15 |
INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) |
| |
| 13:15-13:45 |
Visit to Exhibits - Dessert Break |
| |
| 13:45-15:15 |
RETINA II | Diabetic Macular Edema
|
| Chairs: |
Xiaofeng Lin, China; Susan Bressler, USA |
| 13:45:14:15 |
Debate I: Consider alternative treatment regimens for patients with suboptimal vision responses after first 3 intravitreal anti-VEGF injections |
|
13:45-13:55
|
Yes: Michaella Goldstein, Israel |
|
13:55-14:05
|
No: Voraporn Chikitmongkol, Thailand |
|
14:05-14:15
|
Discussion |
| |
| 14:15-14:45 |
Debate II: For persistent DME after 6 injections, add focal/grid laser |
| 14:15-14:25 |
Yes: Jun Kong, China |
| 14:25-14:35 |
No: Timothy Lai, Hong Kong |
| 14:35-14:45 |
Discussion |
| |
| 14:45-15:15 |
Debate III: Artificial intelligence is ready to be used widely for DR Screening |
| 14:45-14:55 |
Yes |
| 14:55-15:05 |
No: Daniel Ting, Singapore |
| 15:05-15:15 |
Discussion |
| |
| 15:15-16:45 |
RETINA III| Retinal Detachment and Vitrectomy |
| Chairs: |
Joseph Moisseiev, Israel; Taiji Sakamoto, Japan |
| 15:15-15:45 |
Debate I: Non-clearing vitreous hemorrhage in PDR: Try a series of anti-VEGF injections before going to vitrectomy |
|
15:15-15:25
|
Yes: Adrian Koh, Singapore |
|
15:25-15:35
|
No: Taiji Sakamoto, Japan |
|
15:35-15:45
|
Discussion |
| |
| 15:45-16:15 |
Debate II: Vitrectomy alone is superior to a scleral buckle for a total RD with small tear at 1 o'clock in a phakic 40-year old eye |
|
15:45-15:55
|
Yes: Adiel Barak, Israel |
|
15:55-16:05
|
No: Joseph Moisseiev, Israel |
|
16:05-16:15
|
Discussion |
| |
| 16:15-16:45 |
Debate III: Attempt to treat focal vitreomacular traction with gas injection should be tried before considering vitrectomy |
| 16:15-16:25 |
Yes: Shibo Tang, China |
| 16:25-16:35 |
No: Adiel Barak, Israel |
| 16:35-16:45 |
Discussion |
| |
| |
|
|
SATURDAY, FEBRUARY 23, 2019
|
HALL A |
| |
|
|
09:00-10:00
|
Vision Academy in Retina 2019
|
|
Chairs:
|
|
| |
| 09:00-09:10 |
An introduction to Vision Academy |
| |
|
09:10-09:30
|
Debate I: A fellow eye to an eye with actively treated CMV would best be monitored by sophisticated home monitoring technology (PHP, Home OCT)
|
|
09:10-09:15
|
Yes
|
| 09:15-09:20 |
No |
| 09:20-09:25 |
Presentation of viewpoint |
|
09:25-09:30
|
Questions |
| |
|
09:30-09:50
|
Debate II: Futility of treatment: In some cases in which no improvement is anticipated treatment should be stopped
|
|
09:30-09:35
|
Yes
|
| 09:35-09:40 |
No |
|
09:40-09:45
|
Presentation of viewpoint |
|
09:45-09:50
|
Questions |
| |
| 09:50-10:00 |
Looking forward with the Vision Academy |
| |
| 10:00-10:30 |
Visit to Exhibits - Coffee and Refreshment Break |
| |
| 10:30-12:00 |
RETINA IV | Polypoidal Choroidal Vasculopathy
|
| Chairs: |
Adrian Koh, Singapore; Won Ki Lee, South Korea |
| 10:30-11:00 |
Debate I: EVEREST 2 and PLANET results should be compared |
|
10:30-10:40
|
Yes: Won Ki Lee, South Korea |
| 10:40-10:50 |
No: Adrian Koh, Singapore |
|
10:50-11:00
|
Discussion |
| |
| 11:00-11:30 |
Debate II: ICG Angiography is needed to manage most cases of PCV |
|
11:00-11:10
|
Yes
|
| 11:10-11:20 |
No: Voroporn Chaikitmongkol, Thailand
|
| 11:20-11:30 |
Discussion
|
| |
| 11:30-12:00 |
Debate III: OCT-Angiography is useful in management of PCV |
|
11:30-11:40
|
Yes: Gemmy Cheung, Singapore
|
|
11:40-11:50
|
No: Timothy Lai, Hong Kong
|
|
11:50-12:00
|
Discussion |
| |
| 12:00-12:15 |
Visit to Exhibition & Lunch Box Pick Up |
| |
| 12:15-13:15 |
INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) |
| |
| 13:15-13:45 |
Visit to Exhibits - Dessert Break |
| |
| 13:45-15:15 |
RETINA V | Pathologic Myopia
|
| Chairs: |
Hua Yan, China; Joseph Moisseiev, Israel |
| 13:45:14:15 |
Debate I: Reduce children’s time indoors to reduce incidence of pathologic myopia |
|
13:45-13:55
|
Yes |
|
13:55-14:05
|
No |
|
14:05-14:15
|
Discussion |
| |
| 14:15-14:45 |
Debate II: Macular hemorrhage without leakage on fluorescein or ICG angiography should be treated empirically with anti-VEGF therapy or PDT with verteporfin for possible choroidal neovascularization obscured by hemorrhage |
|
14:15-14:25
|
Yes: Young Hee Yoon, South Korea |
|
14:25-14:35
|
No: Shibo Tang, China |
|
14:35-14:45
|
Discussion |
| |
| 14:45-15:15 |
Debate III: Myopic foveoschisis should be treated by vitrectomy |
|
14:45-14:55
|
Yes: Joseph Moissieiv, Israel |
|
14:55-15:05
|
No: Adiel Barak, Israel |
|
15:05-15:15
|
Discussion |
| |
| 15:15-16:45 |
RETINA VI | Retinal Vein Occlusions
|
| Chairs: |
Xiaoling Liang, China; Timothy Lai, Hong Kong |
| 15:15-15:45 |
Debate I: Intravitreal steroids are a viable choice as first line therapy |
|
15:15-15:25
|
Yes: Barry Kuppermann, USA |
|
15:25-15:35
|
No: Gemmy Cheung, Singapore |
|
15:35-15:45
|
Discussion |
| |
| 15:45-16:15 |
Debate II: SCORE 2 results: Choose aflibercept over bevacizumab for macular edema secondary to central retinal vein occlusion |
|
15:45-15:55
|
Yes: Susan Bressler, USA |
|
15:55-16:05
|
No: Young Hee Yoon, South Korea |
|
16:05-16:15
|
Discussion |
| |
| 16:15-16:45 |
Debate III: Unilateral retinal vein occlusions in older individuals typically warrant work-up for systemic disease |
|
16:15-16:25
|
Yes: Paisan Ruamviboonsuk, Thailand |
|
16:25-16:35
|
No |
|
16:35-16:45
|
Discussion |
| |
| 17:00-18:30 |
Think Tank: Controversies Across Ophthalmology
|
| Chairs: |
Xiaxin Li, China; Tin Aung, Singapore; Paisan Ruamviboonsuk, Thailand |
| 17:00-17:30 |
Debate I: Removal of cataract increases the risk of progression of macular degeneration |
|
17:00-17:10
|
Yes: Barry Kuppermann, USA |
|
17:10-17:20
|
No |
|
17:20-17:30
|
Discussion |
| |
| 17:30-18:00 |
Debate II: Big data are the next big thing in ophthalmology |
|
17:30-17:40
|
Yes: Daniel Ting, Singapore |
|
17:40-17:50
|
No: Sherman Valero, Philippines |
|
17:50-18:00
|
Discussion |
| |
| 18:00-18:30 |
Spirinolactone is effective as a treatment for CSR |
|
18:00-18:10
|
Yes |
|
18:10-18:20
|
No: Michaella Goldstein, Israel |
|
18:20-18:30
|
Discussion |
| |
|
| |
|
| |
GLAUCOMA
|
| |
|
|
FRIDAY, FEBRUARY 22, 2019
|
HALL B |
| |
|
| 10:30-12:00 |
GLAUCOMA I | Screening and Monitoring Controversies
|
| Chairs: |
Christopher Leung, Hong Kong |
| 10:30-11:00 |
Debate I: MIGS is a passing fad |
|
10:30-10:40
|
Yes
|
|
10:40-10:50
|
No: Christopher Leung, Hong Kong |
|
10:50-11:00
|
Discussion |
| |
| 11:00-11:30 |
Debate II: Clear lens extraction is indicated for angle-closure glaucoma |
|
11:00-11:10
|
Yes: Tin Aung, Singapore |
|
11:10-11:20
|
No |
|
11:20-11:30
|
Discussion |
| |
| 11:30-12:00 |
Debate III: Genetic profiling has a role in management of glaucoma |
|
11:30-11:40
|
Yes |
|
11:40-11:50
|
No |
|
11:50-12:00
|
Discussion |
| |
| 12:00-12:15 |
Visit to Exhibition & Lunch Box Pick Up |
| |
| 12:15-13:15 |
INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) |
| |
| 13:15-13:45 |
Visit to Exhibits - Dessert Break |
| |
|
| |
|
| |
|
|
SATURDAY, FEBRUARY 23, 2019
|
HALL B |
| |
|
| 13:45-15:15 |
GLAUCOMA II | Management: Present and Future
|
| Chairs: |
Ningli Wang, China; Ryo Asaoka, Japan |
| 13:45:14:15 |
Debate I: Sustained release glaucoma systems will replace eye drops |
|
13:45-13:55
|
Yes: Tin Aung, Singapore |
|
13:55-14:05
|
No |
|
14:05-14:15
|
Discussion |
| |
| 14:15-14:45 |
Debate II: Optic disc photography is outdated when we have OCT |
|
14:15-14:25
|
Yes |
|
14:25-14:35
|
No: Ryo Asaoka, Japan |
|
14:35-14:45
|
Discussion |
| |
| 14:45-15:15 |
Debate III: Neuroprotective therapy for glaucoma will be available in the next 5 years |
|
14:45-14:55
|
Yes: Christopher Leung, Hong Kong |
|
14:55-15:05
|
No: Ryo Asaoka, Japan |
|
15:05-15:10
|
Discussion |
| |
|
| |
|
| |
ANTERIOR SEGMENT |
| |
|
|
FRIDAY, FEBRUARY 22, 2019
|
HALL B |
| |
|
| 13:45-15:15 |
ANTERIOR SEGMENT I | Cataract
|
| Chairs: |
Ehud Assia, Israel |
| 13:45:14:15 |
Debate I: High myopia is best corrected by clear lens extraction |
|
13:45-13:55
|
Yes |
|
13:55-14:05
|
No: Ehud Assia, Israel |
|
14:05-14:15
|
Discussion |
| |
| 14:15-14:45 |
Debate II: Suture fixation is better than intraocular fixation of IOL |
|
14:15-14:25
|
Yes |
|
14:25-14:35
|
No: Shaowei Li, China |
|
14:35-14:45
|
Discussion |
| |
| 14:45-15:15 |
Debate III: Presbyopic correction should be considered in all cataract operations |
|
14:45-14:55
|
Yes |
|
14:55-15:05
|
No: Danying Zheng, China |
|
15:05-15:10
|
Discussion |
| |
|
SATURDAY, FEBRUARY 23, 2019
|
HALL B |
| |
|
| 14:00-15:30 |
ANTERIOR SEGMENT II | Cornea
|
| Chairs: |
|
| 15:15-15:45 |
Debate I: Toric IOLs should be used only in eyes with corneal regular astigmatism |
|
15:15-15:25
|
Yes |
|
15:25-15:35
|
No: Ehud Assia, Israel |
|
15:35-15:45
|
Discussion |
| |
| 15:45-16:15 |
Debate II: DMEK typically is better than DSAEK |
|
15:45-15:55
|
Yes |
|
15:55-16:05
|
No |
|
16:05-16:15
|
Discussion |
| |
| 16:15-16:45 |
Debate III: Laser refractive surgery: Lasik typically should be chosen over SMILE for up to -12 diopters |
|
16:15-16:25
|
Yes |
| 16:25-16:35 |
No |
|
16:35-16:45
|
Discussion |
| |
| |
|
| |
|
| |
NEURO-OPHTHALMOLOGY |
| |
|
|
FRIDAY, FEBRUARY 22, 2019
|
HALL B
|
| |
|
| 15:15-16:45 |
NEURO-OPHTHALMOLOGY I | Afferent
|
| Chairs: |
Andrew Lee, USA |
|
15:15-15:45
|
Debate I: There is treatment for traumatic optic neuropathy
|
|
15:15-15:25
|
Yes |
|
15:25-15:35
|
No: Andrew Lee, USA |
|
15:35-15:45
|
Discussion |
| |
|
15:45-16:15
|
Debate II: There is treatment for non-arteritic anterior ischemic optic neuropathy (NAION) |
|
15:45-15:55
|
Yes: Andrew Lee, USA |
|
15:55-16:05
|
No |
|
16:05-16:15
|
Discussion |
| |
|
16:15-16:45
|
Case Presentations
|
| |
Moderator: Andrew Lee, USA
|
|
Panelist: All Speakers
|
| |
| |
|
| |
|
| |
|
|
SATURDAY, FEBRUARY 23, 2019
|
HALL B
|
| |
|
|
10:30-12:00
|
NEURO-OPHTHALMOLOGY II | Efferent
|
| Chairs: |
Andrew Lee, USA |
|
10:30-11:00
|
Debate I: All patients with acute 6th nerve palsy should be imaged
|
|
10:30-10:40
|
Yes |
|
10:40-10:50
|
No: Andrew Lee, USA |
|
10:50-11:00
|
Discussion |
| |
|
11:00-11:30
|
Debate II: All patients with third nerve palsies should be imaged
|
|
11:00-11:10
|
Yes
|
|
11:10-11:20
|
No: Andrew Lee, USA |
|
11:20-11:30
|
Discussion |
| |
|
11:30-12:00
|
Case Presentations
|
| |
Moderator: Andrew Lee, USA
|
|
Panelist
|
| |
| 12:00-12:15 |
Visit to Exhibition & Lunch Box Pick Up |
| |
| 12:15-13:15 |
INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) |
| |
| 13:15-13:45 |
Visit to Exhibits - Dessert Break |
389